Has Marta Fernandez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,483,539 in general payments to Marta Fernandez, MD across 470 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marta Fernandez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marta Fernandez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marta Fernandez, MD

General Practice · Hollywood, FLNPI 1780666750

Payments from drug & device makers

$5,483,539in general payments, 2019–2025

Across 470 payments — averaging $11,667 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$3.4M
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1M
Otsuka Pharmaceutical Development & Commercialization, Inc.$423K
Evofem Biosciences, Inc.$266K
Astrazeneca UK Limited$174K
AstraZeneca$86K
plus $57K from 15 others

What the payments were for

Food & beverage$1,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	6	$3,448,151
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	279	$1,028,496
Otsuka Pharmaceutical Development & Commercialization, Inc.	8	$422,942
Evofem Biosciences, Inc.	28	$266,377
Astrazeneca UK Limited	1	$174,257
AstraZeneca	9	$86,242
GSK	33	$54,673
Incyte Corporation	26	$808
Merz North America, Inc.	4	$378
Johnson & Johnson	23	$352
AbbVie(2 entities)	15	$244
Lilly USA, LLC	12	$200
Amarin Pharma, Inc.	10	$171
Abbott	5	$72
Pfizer	2	$37
Kowa Pharmaceuticals America, Inc.	2	$34
Sanofi-aventis U.S. LLC	2	$32
Boehringer Ingelheim	2	$27
Nestle Healthcare Nutrition Inc.	1	$17
Cumberland Pharmaceuticals, Inc.	1	$16
Hologic Sales And Service, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$275
BREZTRI$120

How this compares

$5,483,539 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Medicare billing

Part B allowed, 2024

$9,315

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MupirocinMupirocin Calcium	11	$3,242
Diclofenac Sodium	65	$2,326
Ezetimibe	61	$1,280
Clobetasol Propionate	15	$1,133
Gabapentin	49	$1,096
Rosuvastatin Calcium	67	$702
Atorvastatin Calcium	74	$664
Metoprolol Succinate	22	$487
Albuterol Sulfate HfaAlbuterol Sulfate	24	$444
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	17	$402
Vitamin D2Ergocalciferol (Vitamin D2)	86	$358
Benzonatate	12	$349
Eszopiclone	13	$342
Levothyroxine Sodium	44	$283
Alendronate Sodium	37	$265

Paid to pharmacies, not to this prescriber.

Other general practice in Hollywood

Jose CardonaMiami$71M
Lawrence GalitzMiami Gardens$42.5M
Armando AcevedoMiami$15.2M
Jorge AmayaMiami$14.2M
Frank AlvarezHialeah$13.6M
Hector RodriguezMiami$12.8M
Eddie ArmasSouth Miami$12.4M
Idalia AcostaMiami$11.4M
Lilia Rodriguez AblesMiami$10.7M
Jorge Monroy AvellaOcoee$10.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →